medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 615

<< Back Next >>

Rev Med Cos Cen 2015; 72 (615)

Quilotórax

Villalobos MC, Mora HGA
Full text How to cite this article

Language: Spanish
References: 11
Page: 385-389
PDF size: 162.11 Kb.


Key words:

No keywords

ABSTRACT

Chylothorax occurs when there is rupture, laceration or obstruction of the thoracic duct or its main tributaries, resulting in the release of chyle into the pleural space. It most commonly occurs from trauma or malignancy, but other causes have been described. Diagnosis involves thoracocentesis and cholesterol and triglyceride measurement in the pleural fluid. Complications include malnutrition, immunosuppression and respiratory distress. Treatment may be either conservative or aggressive depending on the clinical scenario.


REFERENCES

  1. Bryant A, Minnich D, Wei B, Cerfolio R. The Incidence and Management of Postoperative Chylothorax After Pulmonary Resection and Thoracic Mediastinal Lymph Node Dissection. The Annals of Thoracic Surgery. Volume 98, Issue 1, July 2014, Pages 232–237.

  2. Candas F, Yildizhan A, Gorur R, Isitmangil T.Is bilateral chylothorax possible after simple cough? Yes. Asian Cardiovascular Thoracic Annals. 2014 Jun 13.

  3. Csiszkó A, Herr G, Kiss S, Hallay J, Gyöngyösi Z, Szentkereszty Z. VATS therapy of chylothorax caused by leiomyomatosis complicated with tuberous sclerosis complex. J Minim Access Surg. 2013 Apr-Jun; 9(2): 84–86.

  4. López M, Luengo M, Rangel J, Liso F. Eficacia y seguridad del octreótide asociado a nutrición parenteral totalen el tratamiento conservador del quilotórax. NutriciónHospitalaria. 2012;27 (3):948-949.

  5. Maldonado F, Hawkins FJ, Daniels CE, et al. Pleural fluid characteristics of chylothorax.Mayo ClinProc 2009; 84:129.

  6. McGrath E, Blades Z, Anderson P, Chylothorax: Aetiology, diagnosis and therapeutic options. Respiratory Medicine (2010) 104, 1e8.

  7. Nair SK, Petko M, Hayward MP. Aetiology and management ofchylothorax in adults.Eur J CardiothoracSurg 2007;32(2):362e9.

  8. Pego-Fernandes P, Boldrini M, Ranzani O, Satsuki M, Monteiro R, Biscegli F. Video-assisted thoracoscopy as an option in the surgical treatment of chylothorax after cardiac surgery in children. J Bras Pneumol. 2011;37(1):28-35.

  9. Sirvent M, López P, Martinez M. Soporte nutricional y tratamiento con octreotido del quilotórax.Nutrición Hospitalaria 2010; 25: 113-119.

  10. Talwar A, Lee H. A Contemporary Review of Chylothorax.The Indian Journal of Chest Diseases & Allied Sciences2008; Vol. 50.

  11. Thomas R, Lee Y. Management of Benign and Malignant Pleural Effusions.Thoracic Surgery Clinics. Volume 23, Issue 1, February 2013, 25–42.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2015;72